NDC 63739-549-72 - Megestrol Acetate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 63739-549
- Requested NDC
- 63739-549-72
- Package NDCs from labels
- 63739-549-72, 63739-549-73
- Manufacturer
- McKesson Corporation dba SKY Packaging
- Effective date
- 2024-12-19
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Megestrol Acetate - McKesson Corporation dba SKY Packaging | McKesson Corporation dba SKY Packaging | 2024-12-19 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 63739-549-51 | 2020-07-22 | C162847 | 48780-1 | ab0e2407-2c04-f274-e053-dbdaa90a6471 | Megestrol Acetate Oral Suspension |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 63739-549-51 | ML - Milliliter | 63739-549 | 4218a050-8935-4db7-9268-4fecd258371b | 1 | 2013-04-01 |
| 63739-549-72 | ML - Milliliter | 63739-549 | fc1aef9b-3fa1-4529-a966-d5998914e614 | 1 | 2021-07-15 |
| 63739-549-73 | ML - Milliliter | 63739-549 | 438fec74-c8ae-499c-b4c2-75567abb52d8 | 1 | 2021-07-15 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| MEGESTROL ACETATE | ACTIVE INGREDIENT | TJ2M0FR8ES | MEGESTROL ACETATE SUSPENSION [MCKESSON PACKAGING SERVICES A BUSINESS UNIT OF MCKESSON CORPORATION] | 2 | |
| MEGESTROL | ACTIVE MOIETY | EA6LD1M70M | MEGESTROL ACETATE SUSPENSION [MCKESSON PACKAGING SERVICES A BUSINESS UNIT OF MCKESSON CORPORATION] | 2 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Megestrol Acetate | MEGESTROL ACETATE | ATLANTIC BIOLOGICALS CORP. | 01119031-9943-4afb-8b45-cb71682f0482 | 2026-07-09 | Warnings, Adverse reactions | ANDA075671 TJ2M0FR8ES |
| Megestrol Acetate | MEGESTROL ACETATE | Preferred Pharmaceuticals Inc. | edef65d1-d583-4cee-bb9a-515be84ac51d | 2026-06-15 | Warnings, Adverse reactions | ANDA075671 TJ2M0FR8ES |
| Megestrol Acetate | MEGESTROL ACETATE | Upsher-Smith Laboratories, LLC | 2dc921d5-e423-4379-a345-151e87d13651 | 2026-04-14 | Warnings, Adverse reactions | TJ2M0FR8ES |
| Megestrol Acetate | MEGESTROL ACETATE | Major Pharmaceuticals | e44cf173-991b-43cf-93f2-e0efaa4cc29a | 2026-01-15 | Warnings, Adverse reactions | TJ2M0FR8ES |
| Megestrol Acetate | MEGESTROL ACETATE | Natco Pharma USA LLC | 582cff8a-1def-43d6-ba7e-dce49e3e9f27 | 2026-01-15 | Warnings, Adverse reactions | ANDA075671 TJ2M0FR8ES |
| Megestrol Acetate | MEGESTROL ACETATE | American Health Packaging | 2921731a-6866-4dc8-8f6b-b636abf7bcf8 | 2026-01-05 | Warnings, Adverse reactions | TJ2M0FR8ES |
| Megestrol Acetate | MEGESTROL ACETATE | PAI Holdings, LLC dba PAI Pharma | 2d5b58cd-cbb1-4f5c-b13f-63185c0f8e31 | 2025-10-17 | Warnings, Adverse reactions | TJ2M0FR8ES |
| Megestrol Acetate | MEGESTROL ACETATE | Major Pharmaceuticals | 2c755c6b-32e9-4029-8b70-855007f7375b | 2025-09-15 | Warnings, Adverse reactions | TJ2M0FR8ES |
| Megestrol Acetate | MEGESTROL ACETATE | Kesin Pharma Corporation | 3bc8708e-a52d-fda2-e063-6294a90a0fbc | 2025-09-02 | Warnings, Adverse reactions | ANDA075671 TJ2M0FR8ES |
| Megestrol Acetate | MEGESTROL ACETATE | Xttrium Laboratories, Inc. | 3169f883-4076-32ce-e063-6394a90a4925 | 2025-07-24 | Warnings, Adverse reactions | TJ2M0FR8ES |
| Megestrol Acetate | MEGESTROL ACETATE | Bryant Ranch Prepack | dd6617df-0876-4fc5-8435-b53d29ccc1ae | 2025-03-31 | Warnings, Adverse reactions | TJ2M0FR8ES |
| Megestrol Acetate | MEGESTROL ACETATE | Strides Pharma Science Limited | 8ec70070-da70-4a38-9d58-cf2278517661 | 2025-02-24 | Warnings, Adverse reactions | TJ2M0FR8ES |
| Megestrol Acetate | MEGESTROL ACETATE | Bryant Ranch Prepack | 9b764cf3-4756-4f0e-b747-421d71674313 | 2025-01-17 | Warnings, Adverse reactions | TJ2M0FR8ES |
| fae72fa7-5115-46c1-be4a-3f0846a2a8a4 | 95dfc24a-5744-4ddf-8809-86184142a372 | 2024-12-19 | Warnings, Adverse reactions | 95dfc24a-5744-4ddf-8809-86184142a372 | ||
| Megestrol Acetate | MEGESTROL ACETATE | Golden State Medical Supply, Inc. | 19c33213-7919-208d-e063-6394a90a0f08 | 2024-05-31 | Warnings, Adverse reactions | ANDA075671 TJ2M0FR8ES |
| Megestrol Acetate | MEGESTROL ACETATE | Precision Dose Inc. | bf0d54c5-b813-4f2e-9a37-cbea332cfe53 | 2024-03-28 | Warnings, Adverse reactions | ANDA075671 TJ2M0FR8ES |
| Megestrol Acetate | MEGESTROL ACETATE | Precision Dose Inc. | d0ad931e-4e3e-48bf-9949-77d6971da6e6 | 2024-03-28 | Warnings, Adverse reactions | ANDA075671 TJ2M0FR8ES |
| Megestrol Acetate | MEGESTROL ACETATE | ANI Pharmaceuticals, Inc. | a26dcd78-ad62-4cf5-ad97-49ccb34d43ba | 2024-03-20 | Warnings, Adverse reactions | TJ2M0FR8ES |
| Megestrol Acetate | MEGESTROL ACETATE | Teva Pharmaceuticals USA, Inc. | 66573d39-f2a7-49fd-9ed2-97ac8f6e8456 | 2022-11-30 | Warnings, Adverse reactions | TJ2M0FR8ES |
| Megestrol Acetate | MEGESTROL ACETATE | Strides Pharma Science Limited | 9f7365a0-67cf-45fc-a914-e40a4507a063 | 2022-04-22 | Warnings, Adverse reactions | ANDA075671 TJ2M0FR8ES |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.